Supplementary homeopathic treatment of Corona

Scientific studio in patients suffering from corona in hospital (COVIHOM)*.

It is known that CORONA (COVID-19) is a new, extremely dangerous and life-threatening viral disease that has caused a worldwide pandemic.

Homeopaths from Austria have investigated in a scientific study whether an additional accompanying individualized homeopathic therapy could positively influence the course of patients who had been hospitalized because of CORONA.

Thirteen patients with CORONA infection were hospitalized and treated conventionally according to the latest medical standards. The average age was 73 years, and the oldest patient was 91 years old. Six patients (46.2%) were critically ill and required treatment in the intensive care unit. The encouraging result was that twelve patients (92.3%) were discharged without sequelae after an average of 14 days. The average stay in the ICU of the 5 surviving patients was 19 days. A single patient who had to be admitted in the advanced stage of a septic (severe febrile) illness had died. Shortly after the start of the respective homeopathic treatment, there was a marked improvement in clinical and also subjective symptoms in the 12 surviving patients.

These observations suggest that complementary homeopathic therapy may be helpful in CORONA in addition to conventional treatment.

Regarding these observations, an Israeli-Austrian double-blind, placebo-controlled study had been planned, but could not be conducted due to overload of nursing staff and lack of resources. Currently, the authors are writing a paper on the long-term effects of CORONA (Long COVID-19), and excellent results are also emerging.

The journal Complementary Therapies in Clinical Practice has an impact factor of 1.701, so it is a good, internationally recognized, scientific journal."

*Takacs M, Frass M, Walder G, Fibert P, Rottensteiner M, Glück W, Lechleitner P, Oberbaum M, Leisser I, Chandak K, Panhofer P, Weiermayer P. Adjunctive homeopathic treatment of hospitalized COVID-19 patients (COVIHOM): A retrospective case series. Complement Ther Clin Pract. 2021;44:101415. doi: 10.1016/j.ctcp.2021.101415. epub 2021 May 11. PMID: 33989861.


Leave a comment

Information about Cookies and Data Protection:

This website uses cookies. Cookies are small pieces of text, a web browser stores on the user’s device. They cause no harm.

Cookies that are required for the functionality of the website are set in accordance with Art 6 para. 1 lit b) GDPR (legal basis). All other cookies are only stored providing that you give consent according to Art 6 para. 1 lit a) GDPR (legal basis).

You have the right to withdraw your consent at any time. The withdrawal of consent does not affect the lawfulness of processing based on consent before its withdrawal. You are not obliged to give your consent in order to use the website. You can use the website irrespectively of your given, refused or withdrawn consent. However, the functionality of the website may be limited, when you refuse or withdraw your consent.

The offered information on this website is not addressed to children and persons below the age of 16.

To withdraw your consent or to restrict cookies, you have particularly the following possibilities:

Necessary Cookies:

This website could use the following cookies that are essential for operating the website:

Optional cookies for marketing and analysis purposes:

Cookies that are set for marketing and analysis purposes usually are stored longer than for the particular session; the precise storage time can be learned from the guidelines of the respective providers.

Additional information about the utilization of personal data in connection with the usage of this website can be found in our Data Protection Guidelines in accordance with Art 13 GDPR.